Back to search
Localized Head and Neck Carcinoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Localized Head and Neck Carcinoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Localized Head and Neck Carcinoma trials you may qualify forThis clinical trial compares the effect of geriatric assessment (GA)-based management of supportive care to usual care in treating older patients undergoing che…
This study aims at exploring whether plasma radiofrequency ablation at low temperature is associated with better survival outcome in localized recurrent nasopha…
This phase IV trial is evaluating whether morning versus afternoon administration of standard of care immunotherapy impacts its effectiveness in treating patien…
The aim of this study is to investigate the effect of ATRA (Vesanoid) and the effect of tailored radiotherapy in patients with squamous cell carcinoma of the or…
Arm 1 ( Phase 2/3 Run in ): PRV111: Topical Locoregional Delivery Placed Over the Tumor Region Primary Endpoint: Overall Response Rate (ORR) Primary Objective:…
This trial tests how well personalized ultra fractionated stereotactic adaptive radiotherapy (PULSAR) works together with HyperArc© radiation treatment planning…
This is a phase 3, randomized, double-blind, placebo-controlled study to compare the efficacy and safety of tislelizumab (BGB-A317) versus placebo in combinatio…
This pilot, single-arm clinical study evaluates the feasibility, safety, and effectiveness of radiofrequency ablation (RFA) as a curative treatment for small, l…